We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
The current AMGN market cap is 145.2B. The company's latest EPS is USD 12.2427 and P/E is 22.16.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 6.65B | 6.84B | 6.11B | 6.99B | 6.9B |
| Operating Income | 2.67B | 1.69B | 3.79B | 2.68B | 2.02B |
| Net Income | 2.14B | 1.62B | 2.84B | 1.38B | 1.73B |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 23.75B | 23.36B | 25.42B | 25.98B | 26.32B |
| Operating Income | 10.26B | 9.67B | 9.14B | 7.64B | 9.57B |
| Net Income | 8.39B | 7.84B | 7.26B | 5.89B | 6.55B |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 63.7B | 65.12B | 88.72B | 90.27B | 90.53B |
| Total Liabilities | 60.05B | 61.46B | 83.37B | 83.49B | 82.88B |
| Total Equity | 3.65B | 3.66B | 5.35B | 6.78B | 7.66B |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 66.42B | 59.71B | 62.95B | 61.17B | 65.12B |
| Total Liabilities | 53.92B | 50.03B | 53.54B | 54.47B | 61.46B |
| Total Equity | 12.5B | 9.67B | 9.41B | 6.7B | 3.66B |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | 7.07B | 9.72B | 1.06B | 5.17B | 7.93B |
| Investing | -2.57B | -6.04B | 1.36B | 1.15B | 885M |
| Financing | -2.99B | -4.04B | 21.51B | 20.3B | 18.29B |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | 11.3B | 9.15B | 10.5B | 9.26B | 9.72B |
| Investing | 14.34B | 5.71B | -5.4B | 733M | -6.04B |
| Financing | -22.49B | -15.77B | -4.87B | -8.27B | -4.04B |
| Market Cap | 145.2B |
| Price to Earnings Ratio | 22.16 |
| Price to Sales Ratio | 5.52 |
| Price to Cash Ratio | 19.03 |
| Price to Book Ratio | 39.66 |
| Dividend Yield | 3.14% |
| Shares Outstanding | 535.18M |
| Average Volume (1 week) | 2.07M |
| Average Volume (1 Month) | 2.08M |
| 52 Week Change | -5.3% |
| 52 Week High | 288.46 |
| 52 Week Low | 211.73 |
| Spread (Intraday) | 1.36 (0.5%) |
| Company Name | Amgen Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.amgen.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
|
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions Support: 1-888-992-3836 | help@advfn.com |
| ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil |
| ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico |
| ADVFN France ADVFN US ADVFN Korea |
